1. Guest, the 'News in Brief' for the week beginning 14th June 2021 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice
  3. Contribute to feedback on the CDC Evidence Review, for more details click here
    Dismiss Notice

In progress: Measuring Health in Children with CFS/ME: Refinement, application and evaluation of new PROM (PEACH) in routine practice, Crawley et al

Discussion in 'PsychoSocial ME/CFS Research' started by Andy, Jun 10, 2021.

  1. Andy

    Andy Committee Member (& Outreach when energy allows)

    Messages:
    13,279
    Likes Received:
    95,984
    Location:
    Hampshire, UK
    Funded study in progress.

    Abstract:

    Background: Paediatric Chronic Fatigue Syndrome or Myalgic Encaphalistis (CFS/ME) is disabling and relatively common (1-2% of teenagers). We need to improve treatment but need a well developed Patient Reported Outcome Measure (PROM) to do this. Clinical services and randomised controlled trials use a variety of PROMs but they are largely of poor quality with limited relevance to children s experience of CFS/ME. We have completed the first stage in developing a child-centred measure: Prom Evaluating Adolescent and Child cHronic fatigue (PEACH). However, this contains 63 questions and is too long to be used.

    Aims: Create a high quality, relevant, acceptable child-reported PROM for paediatric CFS/ME called PEACH-Short form (PEACH-SF). Objective 1: Refine PEACH-63 to construct PEACH-SF.

    Objective 2: Check the acceptability and relevance of PEACH-SF. Objective 3: Evaluate the quality, validity, acceptability, reliability and responsiveness of PEACH-SF. Methods: Phase 1:

    Objective 1. Refining PEACH-63. We will recruit 313 children from the Bath Specialist paediatric CFS/ME service and the London Specialist paediatric service to complete PEACH-63 once. This will provide data on >250 children. We will collect questionnaire data online and use both traditional and modern psychometric analyses to perform psychometric evaluation. We will describe measurement data quality, the internal structure of the measure, identify those questions which contribute best which will enable us to reduce the number of questions producing PEACH-short form (PEACH-SF), of approximately 20 questions.

    Objective 2: We will check the acceptability and relevance of PEACH-SF by interviewing participants (approximately 10) on whether we have retained content and face validity. We will observe approximately 10 children and young people complete PEACH-SF using Usability Testing Software and we will discuss PEACH-SF with the CFS/ME Young Peoples Advisory Group. Phase 2 (Field test 2)

    Objective 3. We will recruit a further 313 children and young people (ensuring we have data on >250) to complete PEACH-SF ( approximately 20 questions) at baseline, 2 weeks later (to check temporal stability) and 6 months later (to check measurement responsiveness). We will collect the Clinical Global Improvement Scale (CGI, 1 item) at both time points and the SF-36 physical function short form at 6 months.

    Timelines for delivery: Month 10: Field testing 1 complete. Month 14: PEACH-SF complete. Month 28: Field testing 2 complete. Month 31: Psychometric analyses complete and PEACH-SF ready for use. Impact and Dissemination: Short term impact – improved clinical care as PEACH-SF will be used immediately at the end of this study. Medium to long term impact – improved research in paediatric CFS/ME leading to improved treatments.

    Dissemination: To ensure PEACH-SF is used throughout the NHS, we will work with the British Association for CFS/ME to disseminate to paediatric CFS/ME services, and the AHSN to disseminate to paediatric services and inform NICE. We will publish, and work with the press office to ensure researchers and the public are aware of PEACH-SF.

    Chief Investigator(s):
    Professor Esther Crawley

    Co-investigators:
    Dr Kirstie Haywood, Dr Roxanne Parslow, Dr Terry Segal

    Award:
    £149,457.00

    Start Date:
    February 2020

    End Date:
    September 2022

    https://fundingawards.nihr.ac.uk/award/NIHR200509
     
    Starlight, Hutan, MEMarge and 2 others like this.
  2. Trish

    Trish Moderator Staff Member

    Messages:
    33,029
    Likes Received:
    157,453
    Location:
    UK
    £150,000 funding for yet another questionnaire. This is ridiculous.
     
  3. Trish

    Trish Moderator Staff Member

    Messages:
    33,029
    Likes Received:
    157,453
    Location:
    UK
    I've just googled PEACH questionnaire. There is already a different one with a different purpose with the same name:
    What a bunch of idiots - the can't even check whether the acronym is already in use.
     
    Lidia, FMMM1, Mithriel and 10 others like this.
  4. Denise

    Denise Senior Member (Voting Rights)

    Messages:
    316
    Likes Received:
    1,979
    UGH!
    (Any other comments I have are unpublishable.... And seriously? PEACH? Crawley should not be associated in any way with one of the best of summer's offerings!)
     
  5. Peter Trewhitt

    Peter Trewhitt Senior Member (Voting Rights)

    Messages:
    1,573
    Likes Received:
    15,845
    Should we start a petition demanding that Prof Crawley be limited to only one acronym a year, though even that is one to many.
     
    Simbindi, MEMarge, Milo and 8 others like this.
  6. Snow Leopard

    Snow Leopard Senior Member (Voting Rights)

    Messages:
    2,876
    Likes Received:
    20,033
    Location:
    Australia
    Is this the first questionnaire used for ME/CFS patients where they have bothered (or are planning) to test face validity?
     
    Aslaug, FMMM1, Hutan and 2 others like this.
  7. Sly Saint

    Sly Saint Senior Member (Voting Rights)

    Messages:
    6,141
    Likes Received:
    50,378
    Location:
    UK
    BACME

    to coin an american term, peachy
     
    Last edited by a moderator: Jun 11, 2021
    Simbindi, MEMarge, Hutan and 2 others like this.
  8. Hutan

    Hutan Moderator Staff Member

    Messages:
    14,035
    Likes Received:
    58,791
    Location:
    New Zealand
    Every time I see something new from Crawley, I think 'please, please, (Crawley) just go away'.

    I don't think the lack of a well developed PROM is the main barrier to improving treatment. If Crawley really wants to improve treatment of young people with ME/CFS, a useful thing she could do would be to leave the field, and convince her BPS friends to do so too. Another useful thing would be to stop sopping up all the UK research funding for young people with ME/CFS.

    I don't know what they have in mind for this PROM, but it doesn't sound very good. 150,000 pounds could have gone a long way towards establishing some standards in the use of wearable activity monitoring for young people with ME/CFS. That is, working out how to have reliable objective outcomes for studies.
     
    Last edited: Jun 11, 2021
    Simbindi, Joh, NelliePledge and 10 others like this.
  9. FMMM1

    FMMM1 Senior Member (Voting Rights)

    Messages:
    943
    Likes Received:
    3,816
    Where is the public funding coming from? It might be worth challenging the funding body --- is there a subjective [questionnaire] and an objective [actimetry - electronic activity monitoring] outcome indicator?
     
  10. Trish

    Trish Moderator Staff Member

    Messages:
    33,029
    Likes Received:
    157,453
    Location:
    UK
    FMMM1, Simbindi, Joh and 5 others like this.
  11. Snowdrop

    Snowdrop Senior Member (Voting Rights)

    Messages:
    1,844
    Likes Received:
    12,799
    And of course the NIHR is a labryinthine organisation that reports to the Department of Health and Social Care.

    There seems to be an NGO liaison group that is intermediary to NIRH and D of H:

    https://www.lgcgroup.com/health-research-programme-management/

    Under the 'Who we serve":

    We manage schemes for a variety of funders including the successful outsourced public sector research programmes for the UK Government. Each scheme has different objectives and requirements, ranging from low cost, single studies, to multi-million pound investments involving complex collaborations and arrangements.

    https://www.lgcgroup.com/who-grant-management-serve/

    My cognitive capacities get rather challenged by large webs of links that feed back to each other. So feel free anyone to check for accuracy.

    But I think it's worth us knowing what is going on and how it's getting done.
     
    FMMM1, MEMarge, Simbindi and 2 others like this.
  12. Hutan

    Hutan Moderator Staff Member

    Messages:
    14,035
    Likes Received:
    58,791
    Location:
    New Zealand
    For those interested in the questions @Snowdrop poses - 'What is going on and how is it getting done in the NIHR?', we have this thread:
    Transparency, the MRC and NIHR (UK)

    I think it's important that funders of the continuous stream of rubbish research from BPS proponents are challenged on their decision-making.
     
    Wyva, FMMM1, MEMarge and 7 others like this.
  13. FMMM1

    FMMM1 Senior Member (Voting Rights)

    Messages:
    943
    Likes Received:
    3,816
    There's a Parliamentary (scrutiny) Committee - they have powers to calls "persons and papers" (roughly). So e.g. they can call senior officials in the Department to explain this. Also, the Committee can scrutinise the funding policy/decisions.

    Another route is a Parliamentary question.

    If you look at
    • the "outcome" of this "research" is it stigmatising --- all in the mind
    • this research is it systemically flawed (unblinded studies with subject outcome indicators?) can you link this to the "criticisms" i.e. NICE review downgrading unblinded studies with subject outcome indicators?
     
    MEMarge and Peter Trewhitt like this.

Share This Page